Related Experiment Video
Updated: Mar 24, 2026

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
[Progress due to networking structures. Challenges for the Competence Network Malignant Lymphomas in the Era of
Silke Hellmich1, Natalie Schreiber2, Birgit Fath2
1Kompetenznetz Maligne Lymphome e. V., Klinik I für Innere Medizin, Universitätsklinikum Köln, 50924, Köln, Deutschland. silke.hellmich@uk-koeln.de.
Abstract:
The Competence Network Malignant Lymphomas (KML), founded in 1999 at the initiative of the Federal Ministry of Education and Research (BMBF), brings together interdisciplinary medical and scientific expertise in research on malignant lymphomas. The network helps to release synergies in evidence-based clinical research and contributes to the accelerated transfer of advances in knowledge gained from therapeutic studies for the health care of lymphoma patients. During the regular BMBF funding period (1999-2009) individual sub-projects were hived off, such as the Cochrane Haematological Malignancies Group (CHMG) or the Scientific Institute of Haematologists and Oncologists in Private Practice (WINHO GmbH). At the end of BMBF funding, pivotal KML projects such as the reference diagnostic panel for KML lymphoma study groups, site management support, health care management and the information and communication section could be continued in the scientific association "Kompetenznetz Maligne Lymphome e. V." which was founded in 2005. Due to the recent in-depth understanding of the molecular and genetic mechanisms of lymphomagenesis and the consequent transformation to precision medicine targeting specialised groups of patients, the KML is currently facing the challenge of developing modern study, health-care and information concepts in ever shorter periods of time.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Targeted Cancer Therapies
There are several types of targeted therapies against...

